Deltagen Inc. (DGEN)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0001 - Volume
442,968 - Avg. Volume
0 - Market Cap (intraday)
2.746M - Beta (5Y Monthly) -209.47
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 17, 2007
- 1y Target Est
--
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
www.deltagen.comRecent News: DGEN
Performance Overview: DGEN
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DGEN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DGEN
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.97%
Return on Assets (ttm)
-1.58%
Return on Equity (ttm)
-2.72%
Revenue (ttm)
770k
Net Income Avi to Common (ttm)
-46k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
23k
Total Debt/Equity (mrq)
1.46%
Levered Free Cash Flow (ttm)
66.25k
Research Analysis: DGEN
Company Insights: DGEN
DGEN does not have Company Insights